Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

The "General Dynamics Corporation - Strategy Playbook - 2025 - Strategy Focus, Key Strategies & Plans, SWOT, Trends & Growth Opportunities, Market Outlook" company profile has been added to ...

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

The recent inauguration of GE Aerospace-Lufthansa Technik joint venture XEOS’ CFM International Leap maintenance and testing facility is the latest ramp-up in the narrowbody engine’s aftermarket ...

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027Strengthened cash position expected to support ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

ATLANTA, March 31, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company”), a development-stage biotechnology company developing new medicines to treat pain and ...

The Texas Manufacturing Outlook Survey's index for general business activity fell to minus 16.3 in March, from minus 8.3 in February, a second straight month of contraction and its lowest reading ...

WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

Equities research analysts at Wedbush cut their Q1 2025 EPS estimates for Bicara Therapeutics in a note issued to investors ...

PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA ...